NA-News

South Korea Health Policy Updates – May 2023

May 30, 2023

NA-chapters

Health Care Systems Update in India: The Way Forward

May 23, 2023

NA-HQ

A Health Economist Comments on ChatGPT’s Responses

May 23, 2023

NA-Policy

Pharmacoeconomic Guidelines for Malaysia Second Edition

May 18, 2023

NA-global

Estimating the Return on Investment of Health Technology Assessment India (HTAIn)

May 18, 2023

NA-HQ

Can We Do Better for Health Technology Assessors & Patients? - How to Overcome “Mistrust” in Digital Health Technologies for Asia Pacific

May 17, 2023

NA-Policy

Health Policy Updates from South Korea

Feb 13, 2023

NA-HEORupdates3

A Global View of Risk-Sharing Compensation Mechanisms

Feb 13, 2023

NA-Policy

Japan Update: Discussion Underway for Creating New Drug Pricing Methodology

Feb 13, 2023

NA-accomplishments

ISPOR Awards Council Now Accepting Nominations for HEOR Awards

Feb 13, 2023

NA-chapters

ISPOR Hosts an HTA Roundtable for the Asia Pacific Region

Feb 10, 2023

NA-ISPOR

Value or Volume: Is the APAC Region Transforming into Value-Based Health Care?

Nov 22, 2022

NA-Policy

Health Policy Updates in Asia Pacific – China, Philippines and Singapore

Nov 1, 2022

NA-Policy

Leveraging RWE and Managed Entry Agreements in Asia Pacific

Nov 1, 2022

NA-HQ

Digital Health Innovations: Improving Patient Outcomes and Equity in the Asia Pacific Region

Nov 1, 2022

NA-global

Can New Value Assessment Methods Be Included in Access Decisions by Health Insurance Authorities in China?

Nov 1, 2022

NA-HEORupdates3

2022 Webinar Series - ISPOR New Zealand Chapter

Nov 1, 2022

NA-Policy

Japan Update: The First Case of Temporary Pause of Japan HTA

Nov 1, 2022

NA-global

Inequality in China Affected by the COVID-19 Pandemic

Nov 1, 2022

NA-global

Updates on Health Policies of Traditional Chinese Medicine (TCM) in China

Nov 1, 2022

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×